aphranel Hosts European Doctors at 7 Chinese Clinics
Shanghai – October 30, 2026 -- aphranel®, the regenerative aesthetics brand of MOYOM Biotech, has brought European physicians to China for a week-long clinical exchange, following NMPA Class III approval for its MagiCCrystal CaHA filler in China in 2025 and EU MDR certification in 2026.
Delegation visits seven clinics across four Chinese cities
Dr. Tiago Guimarães and the aphranel® European Medical and Sales Team toured facilities with aphranel®-certified Chinese physicians. Stops included Yestar Medical Aesthetic Hospital and Huamei Zixin Medical Aesthetic Hospital in Guangzhou, and Shenzhen Fanyan Aesthetics and Shenzhen Boai Shuguang Hospital in Shenzhen. The group also visited REAL Medical Aesthetics in Shanghai, and Estee Ryan and JollyHue in Hangzhou.
The programme runs under the banner "Learning in China, Applying in Europe" and forms part of The Norns' Weave, a global academic initiative for physicians.